RELX results suggest 'AI worries look overplayed', Deutsche Bank says

After RELX PLC’s first-half results, Deutsche Bank kept a Buy rating and raised its target to 3,100p from 3,050p, while UBS reiterated Buy with a 3,600p target. UBS cited AI-led organic acceleration, with Scientific, Technical & Medical up to 6% and Legal to 10%, plus 7% organic revenue growth and 70 bps margin expansion. Analysts said AI disruption fears look overplayed but near-term sentiment may lag.

Original reporting
Published Jul 24, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 12:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RELX results suggest 'AI worries look overplayed', Deutsche Bank says — source image
Decision brief

The 30-second read

$RELXBullishMed
01

Why it matters

Reported first-half metrics (7% organic revenue growth, 70 bps margin expansion, STM 6% and Legal 10% growth) are used to argue AI-led acceleration and lack of AI-related disruption, while acknowledging an 'AI overhang' may weigh on shares near term.

02

Market read

Traders get a valuation and narrative check: reported growth and margins are being used to challenge the AI disruption thesis, with targets implying substantial upside but with near-term overhang risk.

03

What to watch

The article relies on analyst interpretation of results; it does not provide guidance changes, contract wins, or quantified AI-related demand shifts beyond organic growth and usage commentary.

Relevance 6/10Novelty 6/10Timing: after-hours/near-term positioning following first-half results coverage and fresh analyst target lift

Background

RELX is discussed as a data and software publisher that has faced investor fears that AI could erode subscription demand.

Company-level read

Ticker impact

$RELXBullishMedium confidence
Context

Article cites RELX first-half results with 7% organic revenue growth, 70 bps margin expansion, and division growth (STM 6%, Legal 10%).

Expected impact

Near-term downside risk from the broader AI overhang may persist, but the fundamentals described support a stabilization or re-rating attempt if investors buy the 'no disruption' message.

Evidence & confidence

The text provides concrete performance metrics and a specific thesis from Deutsche Bank/UBS that AI disruption is not showing up in results, but it is still an analyst interpretation rather than a new company disclosure beyond the referenced first-half print.

Market effects

Supports the read-across that AI-driven disruption fears may be less severe for proprietary-content data and legal/STM software models.

Primarily UK large-cap sentiment via FTSE 100 positioning around RELX.

Could influence global valuation debate for information services and data publishers exposed to AI substitution narratives.

Counterpoint

Even with no evidence of disruption in the first half, investors may still price a longer-term AI substitution risk that is not yet visible in reported organic growth.

Key entities

  • RELX PLC

    FTSE 100 data and software publisher discussed as showing AI-led organic acceleration in first-half results.

  • Deutsche Bank

    Retained buy rating and lifted target to 3,100p, arguing AI worries are overplayed.

  • UBS

    Reiterated buy rating and 3,600p target, citing AI-led organic acceleration and multi-year upsell opportunity.

Related articles

$RELXMed

Relx H1 Earnings Call Highlights

RELX (RELX) reported H1 earnings call highlights, citing growth across Risk, STM, Legal, and Exhibitions. Risk and Insurance benefited from financial crime compliance and digital fraud solutions. STM revenue rose 6% and underlying adjusted operating profit 8%. Legal posted 10% underlying revenue growth and 13% profit growth, driven by Lexis+ with Protégé. Management reiterated full-year growth expectations and said AI token costs are under 1% of costs.

$RELXMed

RELX rises as AI helps with new products and costs

RELX PLC shares rose 1.5% to 2,491p after the FTSE 100 group reported higher first-half revenue and profit. Underlying revenue grew 7% and adjusted operating profit rose 9% to £1.7 billion, with margins improving to 35.5%. The board lifted the interim dividend 7% to 20.9p and said it expects strong full-year growth.

$RELXMed

Why is Relx stock climbing today? By Investing.com

Relx shares rose about 2% in pre-open trading after the company reported H1 2026 interim results. According to Relx, underlying revenue grew 7% to £4,871m and adjusted operating profit rose 9% to £1,727m. Adjusted EPS increased 11% at constant currency, with Legal leading. Relx reaffirmed full-year outlook and said AI-enabled tools supported growth.

$BPMedAI 8/10

FTSE 100 up despite Asia-focused financials falls

The FTSE 100 rose 0.3% to 10,360.32 as oil weakness weighed on majors less than expected; Brent fell to $94.88/bbl. Asia-focused banks and insurers dropped after a report said mainland residents face tighter limits opening offshore accounts in Hong Kong. Prudential fell 7.2%, HSBC 2.2%, Standard Chartered 3.2%. Broadcom sank 14% despite record results.